John E. Flaherty 

Jonathan M.H. Short 

McCARTER & ENGLISH, LLP 

Four Gateway Center 

100 Mulberry Street 

Newark, New Jersey 07102 

(973) 622-4444 

Attorneys for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, and KBI-E Inc. 

Henry J. Renk 

Einar Stole 

Edward H. Rippey 

COVINGTON & BURLING LLP 

One CityCenter 

850 Tenth Street, N.W. 

Washington, D.C. 20001 

(202) 662-6000 

Of Counsel for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, and KBI-E Inc. 

FITZPATRICK, CELLA, HARPER & SCINTO 

1290 A venue of the Americas 

RECEIVED 

New York, New York 10104-3800 

(212) 218-2100 

Of Counsel for Plaintiffs AstraZeneca AB, 

AstraZeneca LP, and KBI-E Inc. 

APR- 9 2015 

AT 8:30 M 

WILLIAM T. WALSH 

CLERK 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF NEW JERSEY 

ASTRAZENECA AB, ASTRAZENECA LP, Civil Action No. 3:13-cv-03038-MLC-DEA 

KBI-E INC., HORIZON PHARMA, INC., and 

POZEN, INC., 

Plaintiffs, 

v. 

ACTA VIS LABORATORIES FL, INC. and 

ACTA VIS PHARMA, INC., 

Defendants. 

JOINT STIPULATION OF DISMISSAL 

. OF COUNTS RELATED TO CERTAIN 

PATENTS 

Case 3:11-cv-02317-MLC-DEA Document 314 Filed 04/09/15 Page 1 of 4 PageID: 7896
WHEREAS Plaintiffs AstraZeneca AB, AstraZeneca LP, KBI-E Inc. (collectively, 

"AstraZeneca"), Horizon Pharma Inc., and Pozen, Inc., and Defendants Actavis Laboratories FL, 

Inc. and Actavis Pharma, Inc. (collectively, "Actavis") are Parties to this patent infringement 

case involving U.S. Patent Nos. 5,714,504 (the "'504 patent"); 5,900,424 (the '"424 patent");; 

6,369,085 (the '"085 patent"); 6,875,872 (the '"872 patent"); 6,926,907 (the '"907 patent"); 

7,411,070 (the '"070 patent"); 7,745,466 (the '"466 patent"); and 8,557,285 (the '"285 patent"); 

WHEREAS AstraZeneca, Horizon Pharma Inc., and Pozen, Inc. filed their Amended 

Complaint (Dkt. 53) on April 10, 2014; 

WHEREAS Actavis filed its Answer, Separate Defenses, and Counterclaims (Dkt. 54) on 

April28, 2014; 

WHEREAS AstraZeneca and Actavis wish to narrow the issues in dispute in this 

litigation and streamline the course of future discovery and the scope of trial; 

WHEREAS Federal Rule of Civil Procedure 41(a) permits parties to dismiss claims 

pursuant to a stipulation of dismissal; and 

THEREFORE, IT IS HEREBY STIPULATED, CONSENTED, AND AGREED TO 

by and between AstraZeneca and Actavis as follows: 

1. AstraZeneca's claims of infringement against Actavis concerning the '504, '085, 

'872, '070, and' 466 patents are hereby dismissed with prejudice. 

2. Actavis's counterclaims against the '424, '504, '085, '872, '070, and '466 patents 

are hereby dismissed with prejudice. 

3. Plaintiffs AstraZeneca AB, AstraZeneca LP, and KBI-E Inc. are dismissed from 

the case. 

1 

Case 3:11-cv-02317-MLC-DEA Document 314 Filed 04/09/15 Page 2 of 4 PageID: 7897
4. The above dismissals do not affect the remaining infringement claims concerning 

the '907 and '285 patents or Acta vis's counterclaims concerning the '907 and '285 patents. 

5. The above dismissals do not affect the infringement claims in the cases that are 

consolidated with the above-captioned matter for purposes of discovery. 

6. Each party is to bear its own fees and costs. 

So stipulated, 

Dated: March 11, 2015 

By: s/J ohn E. Aaherty 

John E. Flaherty 

Jonathan M.H. Short 

MCCARTER & ENGLISH, LLP 

Four Gateway Center 

100 Mulberry Street 

Newark, New Jersey 07102 

(973) 622-4444 

Attorneys for Plaintiffs AstraZeneca 

AB, AstraZeneca LP, and KBI-E Inc. 

Einar Stole 

Edward H. Rippey 

COVINGTON & BURLING LLP 

One CityCenter 

850 Tenth Street, N.W. 

Washington, D.C. 20001 

(202) 662-6000 

Of Counsel for Plaintiffs AstraZeneca 

AB, AstraZeneca LP, and KBI-E Inc. 

Henry J. Renk 

FITZPATRICK, CELLA, HARPER & 

SCINTO 

1290 A venue of the Americas 

New York, New York 10104-3800 

(212) 218-2100 

Of Counsel for Plaintiffs AstraZeneca 

AB, AstraZeneca LP, and KBI-E Inc. 

Respectfully Submitted, 

By: s/Robert J. Fettweis 

Robert J. Fettweis 

TRESSLER LLP 

744 Broad Street 

Suite 1510 

2 

Newark, New Jersey 07102 

Phone: (973) 848-2902 

Fax: (973) 848-0405 

Attorneys for Defendants Actavis 

Laboratories FL, Inc. and Actavis 

Pharma, Inc. 

Steven A. Maddox 

Jeremy J. Edwards 

MADDOX EDWARDS PLLC 

1900 K Street, NW 

Washington, DC 20006 

Phone: (202) 253-9234 

Of Counsel for Defendants Actavis 

Laboratories FL, Inc. and Actavis 

Pharma, Inc. 

Case 3:11-cv-02317-MLC-DEA Document 314 Filed 04/09/15 Page 3 of 4 PageID: 7898
SO ORDERED on this Jffday of A~~JL '2015 

~ J';, ¥ 

Hon. Mary L. Cooper, U.S.D.J. 

3 

Case 3:11-cv-02317-MLC-DEA Document 314 Filed 04/09/15 Page 4 of 4 PageID: 7899